Mark R. Hake

Mark R. Hake

CFA

Mark R. Hake, CFA is a financial analyst and entrepreneur. He has been a Chartered Financial Analyst (CFA) for 31 years and has owned his own investment management and investment research firms that focused on value stocks, both in the U.S. and overseas.

Mark writes over 600 articles per year on stocks, cryptos, SPACs, convertibles, ETFs, and other financial securities. He has been ranked with 5 stars by TipRanks.com (under “Mark R. Hake”) with an average return of over 22% annually and #36 out of 8,116 writers. Presently he authors articles on Medium.com and other sites.

Mark also invests in public and private equities and has acted as a hedge fund manager and portfolio manager for various money management firms. He has also acted as CFO and Chief Strategy Officer for several fin-tech and software companies.

You can follow Mark on LinkedIn and on TipRanks.

Recent Articles

Expect Boeing Stock Volatility After Tomorrow’s Likely Tough Q4 Results

By Mark R. Hake, CFA

Boeing is likely to show a difficult Q4 so expect BA stock to be volatile. The shares could hit $387, or 91.5% higher, once the company turns FCF positive.

All Eyes Are on Palantir Technologies With Its Demo Day Action

By Mark R. Hake, CFA

This week, all eyes are on Palantir, with its Demo Day scheduled for Jan. 26. But PLTR stock looks fairly valued given its recent rise.

Tattooed Chef Looks Fully Valued Despite Expectations of Growth

By Mark R. Hake, CFA

Investors may want to wait for earnings reports before deciding what to do with TTCF stock. Presently, the company looks fully valued.

Advanced Micro Devices Is Priced Too High for Value Investors

By Mark R. Hake, CFA

Advanced Micro Devices shares may not offer value. AMD stock trades for 47 times 2021 earnings, which is too high for value investors.

Ocugen Is Hanging On By a Thread With Its Latest Indian Biotech Deal

By Mark R. Hake, CFA

Ocugen is hanging on by a thread with its latest Indian biotech deal. OCGN stock looks to be a highly speculative play with a negative expected return.

Load More